C50.412 is a valid billable ICD-10 diagnosis code for Malignant neoplasm of upper-outer quadrant of left female breast. It is found in the 2022 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2021 - Sep 30, 2022. ↓ See below for any exclusions, inclusions or special notations
Left | |
---|---|
C50.012 | Malignant neoplasm of nipple and areola, left female breast |
C50.312 | Malignant neoplasm of lower-inner quadrant, left female breast |
C50.412 | Malignant neoplasm of upper-outer quadrant, left female breast |
C50.512 | Malignant neoplasm of lower-outer quadrant, left female breast |
A malignant neoplasm in which there is infiltration of the skin overlying the breast by neoplastic large cells with abundant pale cytoplasm and large nuclei with prominent nucleoli (paget cells). It is almost always associated with an intraductal or invasive ductal carcinoma of the breast.
C61 Malignant neoplasm of prostate.
C50 Malignant neoplasm of breast.
Rule H26 Code 8541/3 (Paget disease and infiltrating duct carcinoma) for Paget disease and invasive duct carcinoma.
Gleason scores of 5 or lower are not used. The lowest Gleason score is 6, which is a low-grade cancer. A Gleason score of 7 is a medium-grade cancer, and a score of 8, 9, or 10 is a high-grade cancer. A lower-grade cancer grows more slowly and is less likely to spread than a high-grade cancer.
The 2022 edition of ICD-10-CM C79. 82 became effective on October 1, 2021. This is the American ICD-10-CM version of C79.
Breast Cancer ICD-10 Code Reference SheetFEMALERightC50.811Malignant neoplasm of overlapping sites, right female breastC50.911Malignant neoplasm of unspecified site, right female breastD05.01Lobular carcinoma in situ, right breast9 more rows
Secondary breast cancer means that a breast cancer has spread to another part of the body. This includes the liver, lungs, brain, or bones. It doesn't include breast cancers that are affecting the lymph glands under the arm. Secondary breast cancer can no longer be cured.
174.9ICD-9 Code 174.9 -Malignant neoplasm of breast (female) unspecified site- Codify by AAPC.
Intraductal carcinoma in situ of unspecified breast D05. 10 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D05. 10 became effective on October 1, 2021.
Invasive ductal carcinoma is cancer (carcinoma) that happens when abnormal cells growing in the lining of the milk ducts change and invade breast tissue beyond the walls of the duct. Once that happens, the cancer cells can spread.
Another term for invasive ductal carcinoma is invasive mammary carcinoma of no special type, because it is the most common type of breast carcinoma. Both invasive ductal carcinomas and invasive lobular carcinomas arise from the cells lining the ducts and lobules in the breast.